CU6 0.29% $6.83 clarity pharmaceuticals ltd

CU6 - Media and Industry News, page-26

  1. 2,083 Posts.
    lightbulb Created with Sketch. 363
    I know @Davisite says we're more advanced than what some media states, but having a look at the full program, I believe clarity is still earlier than its peers.

    255ac is in the main prostate cancer speaking program, whilst clarity is speaking in a program where they're still discussing the viability of cu64/67.

    I believe this shows why moves were made for other radioconjugates, and we're still moving forward. I hope this stays the case until we at least release our P1/2 data. P1 255ac has been out for years, whereas clarity hasn't formally released and Journal articles about their cu67, as it's still in progress.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$6.83
Change
-0.020(0.29%)
Mkt cap ! $2.187B
Open High Low Value Volume
$6.83 $7.05 $6.58 $11.93M 1.755M

Buyers (Bids)

No. Vol. Price($)
1 1461 $6.83
 

Sellers (Offers)

Price($) Vol. No.
$6.90 3341 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.